|
DCAF7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.218400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.401200E-01 |
| Normal-vs-Stage2 |
1.316390E-01 |
| Normal-vs-Stage3 |
7.816400E-01 |
| Normal-vs-Stage4 |
7.134000E-01 |
| Stage1-vs-Stage2 |
3.095000E-01 |
| Stage1-vs-Stage3 |
2.854200E-01 |
| Stage1-vs-Stage4 |
2.586600E-01 |
| Stage2-vs-Stage3 |
7.230000E-02 |
| Stage2-vs-Stage4 |
7.875700E-02 |
| Stage3-vs-Stage4 |
9.118000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.154400E-01 |
| Normal-vs-AfricanAmerican |
1.555410E-01 |
| Normal-vs-Asian |
7.243800E-01 |
| Caucasian-vs-AfricanAmerican |
1.619770E-01 |
| Caucasian-vs-Asian |
8.932000E-01 |
| AfricanAmerican-vs-Asian |
2.858600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.758600E-01 |
| Normal-vs-Female |
5.050200E-01 |
| Male-vs-Female |
8.464200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.719200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.084600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.053600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.886600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.504000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.311000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.881000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.289000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.882200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.564200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.810400E-02 |
| Classical-VS-Follicular |
2.446600E-01 |
| Classical-VS-Other |
1.619010E-01 |
| Classical-VS-Normal |
1.687160E-01 |
| Tall-VS-Follicular |
3.311600E-01 |
| Tall-VS-Other |
5.102800E-01 |
| Tall-VS-Normal |
3.772600E-01 |
| Follicular-VS-Other |
3.385800E-01 |
| Follicular-VS-Normal |
8.896800E-01 |
| Other-VS-Normal |
2.193200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.956000E-01 |
| Normal-vs-N1 |
1.338990E-01 |
| N0-vs-N1 |
6.645500E-02 |
|
|
